__timestamp | Arrowhead Pharmaceuticals, Inc. | Corcept Therapeutics Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 175000 | 25669000 |
Thursday, January 1, 2015 | 382000 | 48925000 |
Friday, January 1, 2016 | 158333 | 79263000 |
Sunday, January 1, 2017 | 31407709 | 155647000 |
Monday, January 1, 2018 | 16142321 | 246032000 |
Tuesday, January 1, 2019 | 168795577 | 300982000 |
Wednesday, January 1, 2020 | 87992066 | 348292000 |
Friday, January 1, 2021 | 138287000 | 360697000 |
Saturday, January 1, 2022 | 232810000 | 396473000 |
Sunday, January 1, 2023 | 240735000 | 475894000 |
Monday, January 1, 2024 | 3551000 |
Cracking the code
In the dynamic world of biotechnology, Corcept Therapeutics Incorporated and Arrowhead Pharmaceuticals, Inc. have carved distinct paths over the past decade. From 2014 to 2023, Corcept's gross profit surged by an impressive 1,755%, reflecting its robust growth trajectory. In contrast, Arrowhead's gross profit, while more volatile, saw a remarkable increase of over 137,000% from its modest beginnings in 2014.
Corcept consistently outperformed Arrowhead, with its gross profit peaking at nearly $476 million in 2023. Arrowhead, despite its fluctuations, reached a high of approximately $241 million in the same year. This disparity highlights Corcept's steady expansion and market strategy.
Interestingly, 2024 data for Corcept is absent, leaving room for speculation on its future performance. As these companies continue to innovate, investors and industry watchers eagerly anticipate their next moves.
Gross Profit Comparison: AstraZeneca PLC and Corcept Therapeutics Incorporated Trends
Gross Profit Trends Compared: Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.
Dr. Reddy's Laboratories Limited and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Exelixis, Inc. vs Corcept Therapeutics Incorporated
Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated: A Detailed Gross Profit Analysis
Lantheus Holdings, Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Corcept Therapeutics Incorporated vs Veracyte, Inc.
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs MorphoSys AG
Gross Profit Trends Compared: Corcept Therapeutics Incorporated vs Vericel Corporation
Key Insights on Gross Profit: Alkermes plc vs Arrowhead Pharmaceuticals, Inc.
Gross Profit Comparison: Arrowhead Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated Trends
Arrowhead Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis